Debate Series - Estro-events.org
Debate Series - Estro-events.org
Debate Series - Estro-events.org
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
sCiEnTiFiC proGrAMME<br />
Saturday 12 May 2012<br />
CliniCal inTERdiSCiPlinaRy PhySiCS RadiObiOlOgy RTT yOung<br />
Page 158 PROgRammE & ExhibiTiOn guidE • ESTRO 31<br />
abS. numbER<br />
> 18F-FLT PET; an early predictor of outcome after<br />
(chemo)radiotherapy in head and neck cancer<br />
B.A.W. Hoeben (The Netherlands), E.G.C. Troost,<br />
C.M. van Herpen, J. Bussink, W.J.G. Oyen, J.H.A.M. Kaanders Pd-0444<br />
> Circulating tumor cells in locally advanced head and neck cancer:<br />
a possible tool to predict response to treatment?<br />
M. Buglione (Italy), G. Salvatore, C. Almici, M. Mangoni, C. Polli,<br />
F. Consoli, F. Paiar, N. Pasinetti, R. Verardi, S.M. Magrini Pd-0445<br />
> Single vocal cord irradiation: a competitive treatment strategy<br />
in early glottic cancer: early results<br />
P. Levendag (The Netherlands), D.N. Teguh, P. Janssen,<br />
F. Keskin-Cambay, P. van Rooij, A. Al-Mamgani, B. Heijmen,<br />
S.L.S. Kwa, J.D.F. Kerrebijn Pd-0446<br />
> Incidence and prognosis of HPV induced oropharyngeal cancer<br />
L. Cerezo (Spain), C. López Elzaurdia, A. de la Torre, D. Suarez,<br />
A. Hervás, A. Ruiz, C. Ballestín, M. López Cabrera Pd-0447<br />
SYMPOSIUM<br />
CoMplEx MUlTi-ModEl ApproAChEs: lUnG<br />
lEaRning ObJECTivES:<br />
1. To learn the impact of various combinations and sequences of radio- and chemotherapy<br />
on the outcome of locally advanced NSCLC<br />
2. To position the role of post-operative radiotherapy in operable NSCLC patients<br />
3. To define the role of targeted therapies in locally advanced NSCLC and learn how<br />
to improve the therapeutic ratio for this disease<br />
4. To revisit the role of radiotherapy in the multi-disciplinary management of NSCLC<br />
10:30 - 11:30 • Auditorium<br />
ChaiR: J. Bernier (Switzerland)<br />
CO-ChaiR: TBC<br />
10:30 > Chemoradiation in NSCLC: divided past, common future?<br />
SPEaKER: J. Belderbos (The Netherlands) SP-0448<br />
Saturday 12 May 2012<br />
abS. numbER<br />
10:50 > Postop RT/ current guidelines and moving points<br />
SPEaKER: C. Le Pechoux (France) SP-0449<br />
11:10 > How to improve the therapeutic ratio for locally advanced<br />
non-small cell lung cancer (LANSCLC)<br />
SPEaKER: R. Komaki (USA) SP-0450<br />
PROFFERED PAPERS<br />
CliniCAl 6: Gi<br />
10:30 - 11:30 • Room 113-114<br />
ChaiR: J. Gérard (France)<br />
CO-ChaiR: G. Mantello (Italy)<br />
10:30 > ACCORD 12 trial of neoadjuvant treatment in rectal cancer:<br />
clinical results at 3 years. On behalf of PRODIGE group<br />
J.P. Gérard (France), D. Azria, S. Gourgou-Bourgade OC-0451<br />
10:40 > Dose-response of tumour regression after pre-operative<br />
chemoradiotherapy for locally advanced rectal cancer<br />
A.L. Appelt (Denmark), J. Ploen, I.R. Vogelius, S.M. Bentzen,<br />
A. Jakobsen OC-0452<br />
10:50 > Positional variation of involved mesorectal lymph nodes during<br />
RT of rectal cancer<br />
B. Hollmann (The Netherlands), J. Nijkamp, J.J. Sonke,<br />
C.A.M. Marijnen OC-0453<br />
11:00 > Blood biomarkers predict response to chemoradiation:<br />
a prospective study on 260 rectal cancer patients<br />
J. Buijsen (The Netherlands), R.G. Van Stiphout,<br />
P.P.C.A. Menheere, G. Lammering, P. Lambin OC-0454<br />
11:10 > Multivariate prediction of follow-up outcome for patients<br />
with pancreatic cancer: a pooled data analysis<br />
G.C. Mattiucci (Italy), R.G.P.M. van Stiphout, S. Alfieri,<br />
F.A. Calvo, J.B. Dubois, B.W. Maidment 111, R.C. Miller,<br />
M. Reni, N. Sharma, M. Falconi OC-0455<br />
ESTRO 31 • PROgRammE & ExhibiTiOn guidE Page 159<br />
sCiEnTiFiC proGrAMME<br />
eSTRO 31
Change language